Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks
Date
2024
Authors
McDonald, E.G.
Lundby, C.
Thompson, W.
Boyd, C.
Farrell, B.
Gagnon, C.
Herbin, J.
Khuong, N.
Moriarty, F.
Pierson, T.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Expert Review of Clinical Pharmacology, 2024; 17(5-6):433-440
Statement of Responsibility
Conference Name
Abstract
Introduction: Over the past decade, polypharmacy has increased dramatically. Measurable harms include falls, fractures, cognitive impairment, and death. The associated costs are massive and contribute substantially to low-value health care. Deprescribing is a promising solution, but there are barriers. Establishing a network to address polypharmacy can help overcome barriers by connecting individuals with an interest and expertise in deprescribing and can act as an important source of motivation and resources.
Areas covered: Over the past decade, several deprescribing networks were launched to help tackle polypharmacy, with evidence of individual and collective impact. A network approach has several advantages; it can spark interest, ideas and enthusiasm through information sharing, meetings and conversations with the public, providers, and other key stakeholders. In this special report, the details of how four deprescribing networks were established across the globe are detailed.
Expert opinion: Networks create links between people who lead existing and/or budding deprescribing practices and policy initiatives, can influence people with a shared passion for deprescribing, and facilitate sharing of intellectual capital and tools to take initiatives further and strengthen impact. This report should inspire others to establish their own deprescribing networks, a critical step in accelerating a global deprescribing movement.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2024 The Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. (https://creativecommons.org/licenses/by-nc-nd/4.0/)